Literature DB >> 9822269

T lymphocytes are not the target for estradiol-mediated suppression of DTH in reconstituted female severe combined immunodeficient (SCID) mice.

M Taube1, L Svensson, H Carlsten.   

Abstract

Oestrogen has the capacity to suppress T cell-dependent DTH. To explore the mechanisms whereby oestrogen exerts its effects on the immune system we have used SCID mice which are largely devoid of functional T and B lymphocytes, hence being unable to raise DTH, but display intact antigen-presenting capacity. Transfer of lymphocytes to SCID mice restores the DTH capacity. In order to analyse if oestrogen down-regulates DTH by a direct action on T cells we reconstituted SCID mice with either splenocytes or thymocytes from congenic C.B-17 or allogeneic B6 donor mice. Either donor or recipient mice were exposed to estradiol before cell transfer. DTH response was registered in recipient SCID mice 1 and 3 weeks after challenge with oxazolone (OXA). SCID mice receiving estradiol-exposed spleen cells from congenic or allogeneic donor mice displayed lower DTH responses compared with control mice. In contrast, SCID mice receiving estradiol-exposed thymocytes from congenic donor mice showed no significant difference in DTH response compared with control mice. Estradiol-treated SCID mice, transferred with either spleen cells or thymocytes from congenic, hormonally non-treated donors, displayed a significantly lower DTH response compared with control mice. In contrast, estradiol-treated SCID mice receiving hormonally non-treated allogeneic spleen cells showed no difference in DTH response compared with control mice. The results show that T lymphocytes are not the target cell population for estradiol-mediated suppression of DTH in reconstituted female SCID mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822269      PMCID: PMC1905113          DOI: 10.1046/j.1365-2249.1998.00700.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression.

Authors:  T Caulin-Glaser; C A Watson; R Pardi; J R Bender
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils.

Authors:  E Josefsson; A Tarkowski; H Carlsten
Journal:  Cell Immunol       Date:  1992-06       Impact factor: 4.868

3.  Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina.

Authors:  C R Wira; R M Rossoll
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

Review 4.  Estrogens, the immune response and autoimmunity.

Authors:  M Cutolo; A Sulli; B Seriolo; S Accardo; A T Masi
Journal:  Clin Exp Rheumatol       Date:  1995 Mar-Apr       Impact factor: 4.473

5.  In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.

Authors:  S H Zuckerman; N Bryan-Poole; G F Evans; L Short; A L Glasebrook
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

6.  Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1.

Authors:  M C Cid; H K Kleinman; D S Grant; H W Schnaper; A S Fauci; G S Hoffman
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

7.  Presence of estrogen-binding sites on macrophage-like synoviocytes and CD8+, CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium.

Authors:  M Cutolo; S Accardo; B Villaggio; P Clerico; M Bagnasco; D A Coviello; G Carruba; M lo Casto; L Castagnetta
Journal:  Arthritis Rheum       Date:  1993-08

8.  Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice.

Authors:  H Carlsten; N Nilsson; R Jonsson; K Bäckman; R Holmdahl; A Tarkowski
Journal:  Cell Immunol       Date:  1992-10-01       Impact factor: 4.868

9.  A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis.

Authors:  G M Hall; M Daniels; E C Huskisson; T D Spector
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

Review 10.  The SCID mouse mutant: definition, characterization, and potential uses.

Authors:  M J Bosma; A M Carroll
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

View more
  5 in total

1.  Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.

Authors:  S Cenci; M N Weitzmann; C Roggia; N Namba; D Novack; J Woodring; R Pacifici
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  Sex-associated hormones and immunity to protozoan parasites.

Authors:  C W Roberts; W Walker; J Alexander
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo.

Authors:  C Roggia; Y Gao; S Cenci; M N Weitzmann; G Toraldo; G Isaia; R Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

4.  IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells.

Authors:  Gianluca Toraldo; Cristiana Roggia; Wei-Ping Qian; Roberto Pacifici; M Neale Weitzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-18       Impact factor: 11.205

5.  Ex vivo inhibition of NF-kappaB signaling in alloreactive T-cells prevents graft-versus-host disease.

Authors:  M J O'Shaughnessy; C Vogtenhuber; K Sun; R Sitcheran; A S Baldwin; W J Murphy; L Dang; B Jaffee; E Palmer; J S Serody; B R Blazar
Journal:  Am J Transplant       Date:  2009-03       Impact factor: 8.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.